Search

A blood condition related to aging can lead to misinterpreting tumor data.

… Tuesday, June 5, 2018 Summary MSK researchers have found that clonal hematopoiesis (CH) can be misinterpreted as tumor mutations in sequencing tests. CH is a blood condition related to aging that can cause mutations in the blood. Misreading such results could affect treatment decisions. MSK-IMPACT TM

Learn how MSK researchers are investigating the use of nanoparticles to carry drugs across the blood-brain barrier.

… Thursday, March 2, 2023 The blood-brain barrier prevents most drugs from reaching brain tumors. A new method using nanoparticles transported drugs across this barrier in mice. The nanoparticles target a protein on tumor blood vessel cells called P-selectin. The nanoparticles improved the treatment in

Scientists and scholars received degrees and awards at MSK's 40th annual ceremony, held on May 29.

… Friday, May 31, 2019 The GSK class of 2019 The newly minted graduates look on during the ceremony. Craig Thompson, President and CEO of MSK Craig Thompson, President and CEO of MSK, applauds the bright young minds at the 2019 Convocation and Commencement of the Gerstner Sloan Kettering Graduate School

Learn how the Pediatric Translational Medicine Program at Memorial Sloan Kettering is bringing together experts to make new discoveries about pediatric cancer.

… Wednesday, March 6, 2019 Summary A new program at MSK seeks to further harness the power of collaboration to give children innovative treatments, which will in turn help other kids down the line. At MSK Kids, our team of experts puts caring for children and their families in the center of all we do.

The in-person event featured scientific talks from leading women in science, including winners of this year’s Kravis WISE fellowships.

… Thursday, April 14, 2022 Three women standing next to each other in a lobby Marie-Josée Kravis (middle) with 2022 Kravis WiSE fellowship winners Xiuzhen Chen (left) and Brianna Naizir (right) A female scientist speaking at a podium Erika Pearce, PhD, Bloomberg Distinguished Professor at the Johns Hopkins

The incidence of mouth and throat cancer is on the rise due to oral transmission of the human papilloma virus, but the "silver lining" of this phenomenon is doctors at Memorial Sloan Kettering have significantly reduced the intensity of treatment while achieving excellent outcomes for these patients.

… Wednesday, February 15, 2017 The incidence of mouth and throat cancer is on the rise due to transmission of the human papilloma virus (HPV), but the “silver lining” of this phenomenon is doctors at Memorial Sloan Kettering (MSK) can significantly reduce the intensity of treatment and improve quality

The updated dietary guidelines from the federal government have caused confusion, but MSK dietitians' recommendations have not changed: A diet that is mostly plant based is still considered the most healthy.

… Wednesday, March 11, 2026 VIDEO | 01:16 MSK Explains: The New Food Pyramid MSK registered dietitian-nutritionist Christina Stella helps break down how to interpret the latest U.S. federal dietary guidelines. Video Details If you’ve heard about the new federal dietary guidelines and feel a little confused

In an effort to expand and streamline patient access to its high-quality cancer care, Memorial Sloan Kettering Cancer Center has introduced MSK Direct, a unique program in which MSK collaborates with external employers to simplify how their employees can engage with us for initial or ongoing cancer care.

… Wednesday, September 21, 2016 In an effort to expand and streamline patient access to its high-quality cancer care, Memorial Sloan Kettering Cancer Center (MSK) has introduced MSK Direct, a unique program in which MSK collaborates with external employers to simplify how their employees can engage with

Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.

… Thursday, July 1, 2010 Summary Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute. Harold

Dr. Sawyers is recognized for his dedication to cancer research, education, collaboration, science policy, advocacy, and funding.

… Friday, April 9, 2021 Memorial Sloan Kettering (MSK) is proud to announce that Charles L. Sawyers, MD, FAACR , Chair of MSK’s Human Oncology and Pathogenesis Program (HOPP) and Howard Hughes Medical Institute Investigator, will receive the 2021 American Association for Cancer Research (AACR) Distinguished